AI models used in regulated industries like healthcare face a significant compliance gap, where passing internal validation does not guarantee success in regulatory audits. This is because AI systems, unlike traditional deterministic software, can drift and change post-deployment, requiring continuous monitoring and robust documentation. Companies must implement end-to-end traceability, controlled model evolution, human oversight, and transparent performance reporting to meet stringent requirements like those from the FDA and the EU's AI Act. AI
IMPACT Highlights critical compliance hurdles for AI adoption in healthcare and other regulated sectors, emphasizing the need for robust traceability and oversight.
RANK_REASON Article discusses the challenges and requirements for AI compliance in regulated industries, offering analysis and expert opinion rather than announcing a new product or research.
- Artificial Intelligence Act
- EU
- Itje Trisnawati
- Maritza Diaz
- Title 21 CFR Part 11
- United States Food and Drug Administration
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
